Proteins do matter: Pharmacoproteomics low hanging fruits for global health and applications in developing countries

Victor P. Andreev

Research output: Contribution to journalReview article


This feature article provides an overview of the nascent field of pharmacoproteomics, its definitions and role in personalized medicine, and the specifications of pharmacoproteomics in developing countries. The "ideal world view" is outlined on the opportunities for pharmacoproteomics in the developing countries, for example, research in the fields of neglected tropical diseases and the potential merger of traditional holistic eastern medicine approaches and the practice of personalized medicine. An innovation analysis is performed on the distribution of pharmacoproteomics publications across the countries, and the types of publications (original research versus reviews). Pharmacoproteomics publications in the developing countries are analyzed in further detail, revealing the lower percentage of original research and higher percentage of reviews illustrating both the intention to develop pharmacoproteomics and the limitations in resources and access to the high-end proteomics instrumentation.

Original languageEnglish (US)
Pages (from-to)271-276
Number of pages6
JournalCurrent Pharmacogenomics and Personalized Medicine
Issue number4
StatePublished - Dec 1 2012



  • Developing countries
  • Global personalized medicine
  • Neglected tropical diseases
  • Omics data-intensive science
  • Pharmacoproteomics

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine
  • Pharmacology
  • Molecular Biology
  • Genetics(clinical)

Cite this